These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation. Pellesi L; Chaudhry BA; Vollesen ALH; Snoer AH; Baumann K; Skov PS; Jensen RH; Ashina M Cephalalgia; 2022 Jul; 42(8):687-695. PubMed ID: 34822741 [TBL] [Abstract][Full Text] [Related]
3. The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache. Vollesen ALH; Snoer A; Chaudhry B; Petersen AS; Hagedorn A; Hoffmann J; Jensen RH; Ashina M Cephalalgia; 2020 Nov; 40(13):1474-1488. PubMed ID: 32962406 [TBL] [Abstract][Full Text] [Related]
4. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial. Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329 [TBL] [Abstract][Full Text] [Related]
5. Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Amin FM; Hougaard A; Schytz HW; Asghar MS; Lundholm E; Parvaiz AI; de Koning PJ; Andersen MR; Larsson HB; Fahrenkrug J; Olesen J; Ashina M Brain; 2014 Mar; 137(Pt 3):779-94. PubMed ID: 24501094 [TBL] [Abstract][Full Text] [Related]
6. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache. Nicolodi M; Del Bianco E Cephalalgia; 1990 Feb; 10(1):39-50. PubMed ID: 1690601 [TBL] [Abstract][Full Text] [Related]
9. The role of genetics on migraine induction triggered by CGRP and PACAP38. Guo S Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260603 [TBL] [Abstract][Full Text] [Related]
10. The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study. Rasmussen NB; Deligianni C; Christensen CE; Karlsson WK; Al-Khazali HM; Van de Casteele T; Granhall C; Amin FM; Ashina M J Headache Pain; 2023 May; 24(1):60. PubMed ID: 37231350 [TBL] [Abstract][Full Text] [Related]
12. Hyperbaric oxygen treatment of active cluster headache: a double-blind placebo-controlled cross-over study. Nilsson Remahl AI; Ansjön R; Lind F; Waldenlind E Cephalalgia; 2002 Nov; 22(9):730-9. PubMed ID: 12421159 [TBL] [Abstract][Full Text] [Related]
13. PACAP38 induces migraine-like attacks in patients with migraine without aura. Schytz HW; Birk S; Wienecke T; Kruuse C; Olesen J; Ashina M Brain; 2009 Jan; 132(Pt 1):16-25. PubMed ID: 19052139 [TBL] [Abstract][Full Text] [Related]
14. Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study. Deligianni C; Pellesi L; Chaudhry BA; Haulund Vollesen AL; Snoer AH; Hannibal J; Jensen RH; Ashina M Front Neurol; 2023; 14():1135246. PubMed ID: 37143998 [TBL] [Abstract][Full Text] [Related]
15. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Goadsby PJ; Edvinsson L Brain; 1994 Jun; 117 ( Pt 3)():427-34. PubMed ID: 7518321 [TBL] [Abstract][Full Text] [Related]
16. Effect of the H Vollesen LH; Guo S; Andersen MR; Ashina M Cephalalgia; 2019 Apr; 39(5):597-607. PubMed ID: 30165750 [TBL] [Abstract][Full Text] [Related]
17. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice. Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099 [TBL] [Abstract][Full Text] [Related]
18. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Fanciullacci M; Alessandri M; Figini M; Geppetti P; Michelacci S Pain; 1995 Feb; 60(2):119-123. PubMed ID: 7540279 [TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment. Ashina H; Newman L; Ashina S Neurol Sci; 2017 Dec; 38(12):2089-2093. PubMed ID: 28856479 [TBL] [Abstract][Full Text] [Related]